Efficacy of a Gal-lectin subunit vaccine against experimental Entamoeba histolytica infection and colitis in baboons ( Papio sp.)

Highlights ► Developed a new experimental model of E. histolytica infection in baboons. ► E. histolytica infection and inflammatory colitis was sustained for 90 days. ► A Gal-lectin-based intranasal synthetic peptide vaccine was efficacious. ► Vaccine efficacy was validated by fecal PCR, colonoscopy...

Full description

Saved in:
Bibliographic Details
Published inVaccine Vol. 30; no. 20; pp. 3068 - 3075
Main Authors Abd Alla, Mohamed D, Wolf, Roman, White, Gary L, Kosanke, Stanley D, Cary, David, Verweij, Jaco J, Zhang, Mie-Jie, Ravdin, Jonathan I
Format Journal Article
LanguageEnglish
Published Netherlands Elsevier Ltd 26.04.2012
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Highlights ► Developed a new experimental model of E. histolytica infection in baboons. ► E. histolytica infection and inflammatory colitis was sustained for 90 days. ► A Gal-lectin-based intranasal synthetic peptide vaccine was efficacious. ► Vaccine efficacy was validated by fecal PCR, colonoscopy and pathology. ► Immunity correlated with the ELISA OD value for intestinal anti-lectin IgA.
Bibliography:http://dx.doi.org/10.1016/j.vaccine.2012.02.066
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:0264-410X
1873-2518
DOI:10.1016/j.vaccine.2012.02.066